Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $730.87 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $378.32 | 33 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $194.83 | 13 | $0 (2024) |
| ABBVIE INC. | $74.07 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $21.98 | 1 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $16.92 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $16.01 | 1 | $0 (2021) |
| Ardelyx, Inc. | $15.04 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $13.70 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $343.60 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($147.07) |
| 2023 | $236.97 | 21 | Takeda Pharmaceuticals U.S.A., Inc. ($193.81) |
| 2022 | $52.41 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($37.44) |
| 2021 | $97.89 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($64.96) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Gastroenterology | ||||||
| 05/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Gastroenterology | ||||||
| 01/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 164 | 165 | $137,211 | $19,202 |
| 2022 | 9 | 185 | 185 | $125,854 | $17,651 |
| 2021 | 7 | 148 | 150 | $90,168 | $14,570 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 41 | 42 | $29,328 | $4,070 | 13.9% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 35 | 35 | $27,972 | $4,044 | 14.5% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 40 | 40 | $27,122 | $4,038 | 14.9% |
| 01210 | Anesthesia for other procedure on hip joint | Facility | 2023 | 13 | 13 | $19,980 | $2,672 | 13.4% |
| 01230 | Anesthesia for procedure on upper 2/3rd of thigh bone | Facility | 2023 | 12 | 12 | $17,724 | $2,370 | 13.4% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 23 | 23 | $15,085 | $2,007 | 13.3% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 31 | 31 | $23,363 | $4,158 | 17.8% |
| 01630 | Anesthesia for other procedure on top of arm bone and shoulder joint | Facility | 2022 | 13 | 13 | $18,850 | $2,722 | 14.4% |
| 01402 | Anesthesia for procedure for total knee joint replacement | Facility | 2022 | 11 | 11 | $19,890 | $2,627 | 13.2% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 24 | 24 | $12,563 | $2,460 | 19.6% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 16 | 16 | $10,647 | $1,937 | 18.2% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 14 | 14 | $7,146 | $1,320 | 18.5% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 38 | 38 | $9,045 | $881.53 | 9.7% |
| 64415 | Injection of anesthetic agent and/or steroid into arm nerve bundle | Facility | 2022 | 18 | 18 | $12,240 | $871.09 | 7.1% |
| 64447 | Injection of anesthetic agent and/or steroid into thigh nerve | Facility | 2022 | 20 | 20 | $12,110 | $674.30 | 5.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 36 | 37 | $21,189 | $3,890 | 18.4% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 25 | 25 | $20,306 | $3,518 | 17.3% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 18 | 18 | $13,486 | $2,310 | 17.1% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 21 | 21 | $10,043 | $1,969 | 19.6% |
| 00520 | Anesthesia for closed procedure in chest | Facility | 2021 | 11 | 12 | $12,030 | $1,805 | 15.0% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 24 | 24 | $5,379 | $582.00 | 10.8% |
| 64447 | Injection of anesthetic agent and/or steroid into femoral nerve of thigh | Facility | 2021 | 13 | 13 | $7,735 | $495.36 | 6.4% |
About Jessica Franklin, CRNA
Jessica Franklin, CRNA is a Nurse Anesthetist, Certified Registered healthcare provider based in Norman, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2020. The National Provider Identifier (NPI) number assigned to this provider is 1649886417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Franklin, CRNA has received a total of $730.87 in payments from pharmaceutical and medical device companies, with $343.60 received in 2024. These payments were reported across 55 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($730.87).
As a Medicare-enrolled provider, Franklin has provided services to 497 Medicare beneficiaries, totaling 500 services with total Medicare billing of $51,422. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered
- Location Norman, OK
- Active Since 09/17/2020
- Last Updated 09/17/2020
- Taxonomy Code 367500000X
- Entity Type Individual
- NPI Number 1649886417
Products in Payments
- ENTYVIO (Biological) $298.49
- XIFAXAN (Drug) $180.55
- GATTEX (Drug) $79.83
- RINVOQ (Biological) $74.07
- DUPIXENT (Biological) $21.98
- Exparel (Drug) $16.92
- BRIDION (Drug) $16.01
- IBSRELA (Drug) $15.04
- TRULANCE (Drug) $14.28
- STELARA (Biological) $13.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Anesthetist, Certified Registered Doctors in Norman
Sally Kennedy
Nurse Anesthetist, Certified Registered — Payments: $2,090
Bruce Kennedy, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $546.49
Ryan Peacock, C.r.n.a, C.R.N.A
Nurse Anesthetist, Certified Registered — Payments: $334.64
Shawn Mayhew, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $249.64
Randy Rogers, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $244.91
Courtney Smith, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $181.31